Accuray Inc (LTS:0H8I)
$ 1.7386 -0.0394 (-2.22%) Market Cap: 171.69 Mil Enterprise Value: 318.23 Mil PE Ratio: 0 PB Ratio: 4.18 GF Score: 55/100

Accuray Inc Analyst and Investor Virtual Meeting Transcript

Oct 26, 2020 / 05:00PM GMT
Release Date Price: $2.55
Ken Mobeck

Welcome to Accuray's Annual Investor Day meeting to review our new vision, strategy and product road map. My name is Ken Mobeck, and I'm the Vice President of Finance and Investor Relations here at Accuray. Joining us today are Josh Levine, President and Chief Executive Officer; Suzanne Winter, Chief Commercial Officer and Senior Vice President of R&D; Corey Lawson, Vice President, Product Strategy; Shawn Prince, Senior Director, Patient Access, and Shig Hamamatsu, Chief Financial Officer.

Before we begin, I would like to remind you that our presentation today includes forward-looking statements, including statements related to our product road map, growth and growth catalysts. Actual results may differ materially from those contemplated or implied by these forward-looking statements. Factors that could cause these results to differ materially are set forth in the slides accompanying today's presentation, which we filed on Form 8-K today prior to market open, as well as in our other filings with the Securities and Exchange Commission.

The forward-looking statements contained in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot